The current landscape of NKT cell immunotherapy and the hills ahead
Simple Summary Natural killer T (NKT) cells are a subset of lipid-reactive T cells that
enhance anti-tumor immunity. While preclinical studies have shown NKT cell …
enhance anti-tumor immunity. While preclinical studies have shown NKT cell …
The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy
R Li, L Cao - Frontiers in Immunology, 2023 - frontiersin.org
The treatment outcome of breast cancer is closely related to estrogen receptor (ER),
progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) …
progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) …
Ketogenesis attenuates KLF5-dependent production of CXCL12 to overcome the immunosuppressive tumor microenvironment in colorectal cancer
R Wei, Y Zhou, C Li, P Rychahou, S Zhang, WB Titlow… - Cancer research, 2022 - AACR
The dynamic composition of the tumor microenvironment (TME) can markedly alter the
response to targeted therapies for colorectal cancer. Cancer-associated fibroblasts (CAF) …
response to targeted therapies for colorectal cancer. Cancer-associated fibroblasts (CAF) …
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence
Abstract Background Tumour infiltrating lymphocytes (TILs) are a prognostic parameter in
triple-negative and human epidermal growth factor receptor 2 (HER2)-positive breast cancer …
triple-negative and human epidermal growth factor receptor 2 (HER2)-positive breast cancer …
Identification and validation of m6A-related lncRNA signature as potential predictive biomarkers in breast cancer
W Lv, Y Wang, C Zhao, Y Tan, M Xiong, Y Yi… - Frontiers in …, 2021 - frontiersin.org
The metastasis and poor prognosis are still regarded as the main challenge in the clinical
treatment of breast cancer (BC). Both N6-methyladenosine (m6A) modification and lncRNAs …
treatment of breast cancer (BC). Both N6-methyladenosine (m6A) modification and lncRNAs …
[HTML][HTML] Potential therapeutic and prognostic values of LSM family genes in breast cancer
Simple Summary The roles of “like-Smith”(LSM) proteins in breast cancer development and
their clinical relevance remain unclear. In this study, multiple analyses based on 3593 …
their clinical relevance remain unclear. In this study, multiple analyses based on 3593 …
CCL5 mediates breast cancer metastasis and prognosis through CCR5/Treg cells
J Qiu, L Xu, X Zeng, H Wu, F Liang, Q Lv, Z Du - Frontiers in Oncology, 2022 - frontiersin.org
Background and aims CCL5 is considered to contribute to the biological function of a variety
of cancer types, but its specific mechanism is still unclear. This study aimed to reveal the …
of cancer types, but its specific mechanism is still unclear. This study aimed to reveal the …
T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution
W Yang, S Liu, M Mao, Y Gong, X Li, T Lei… - Journal of Experimental …, 2024 - Springer
Tumor-infiltrating T cells recognize, attack, and clear tumor cells, playing a central role in
antitumor immune response. However, certain immune cells can impair this response and …
antitumor immune response. However, certain immune cells can impair this response and …
Response to immune checkpoint blockade improved in pre-clinical model of breast cancer after bariatric surgery
Bariatric surgery is a sustainable weight loss approach, including vertical sleeve
gastrectomy (VSG). Obesity exacerbates tumor growth, while diet-induced weight loss …
gastrectomy (VSG). Obesity exacerbates tumor growth, while diet-induced weight loss …
Combination of a STING Agonist and Photothermal Therapy Using Chitosan Hydrogels for Cancer Immunotherapy
C Chen, M Hu, Y Cao, B Zhu, J Chen, Y Li… - …, 2023 - ACS Publications
Cyclic dinucleotides (CDNs) are a promising class of immune agonists that trigger the
stimulator of interferon genes (STING) to activate both innate and acquired immunity …
stimulator of interferon genes (STING) to activate both innate and acquired immunity …